Multiple Sclerosis Clinic at the Medical College of Wisconsin

Milwaukee, Wisconsin

Academic MS Center
19 Active TrialsVirtual CareLarge Center
6 MS centers statewide · Ranked #1 in Wisconsin for clinical trials
What kind of place is this?
Comprehensive Care TeamResearch FocusedVirtual Care Available

You’ll find an academic MS center where your care is coordinated by a multidisciplinary team that works across several specialties. You can expect thoughtful evaluation, education, and treatment support, plus virtual visits and second opinions when they fit your needs. You may find this setting more structured than a small neighborhood clinic because it is a large specialty center.

Facility Profile
Synthesized from this facility's public website and data sources. Not a recommendation or ranking — just a summary to help you orient.
Direct Doctor Access2/5
Support Services5/5
Clinical Trials & Research4/5
Insurance & Navigation Help2/5
Scheduling & Virtual Care4/5

About Multiple Sclerosis Clinic at the Medical College of Wisconsin

This clinic stands out for its academic, multidisciplinary approach and broad specialty coordination. You also have access to active clinical trials through the Froedtert & Medical College of Wisconsin system.

Multiple Sclerosis Clinic at the Medical College of Wisconsin serves people living with multiple sclerosis, clinically isolated syndrome, and related central nervous system immune disorders. Care is team-based and includes diagnosis, treatment, symptom management, education, and specialty coordination with urology, neuro-ophthalmology, rehabilitation, and neuropsychology. Patients can also seek second opinions and virtual visits, making care more flexible for follow-up and ongoing support. As an academic center in the Froedtert & Medical College of Wisconsin health network, it combines specialty care with research access and recognized MS expertise.

Multiple Sclerosis Clinic at the Medical College of Wisconsin is an academic MS center in Milwaukee that brings together neurologists, therapists, pharmacists, and other specialists in one coordinated setting. You can get help with MS diagnosis, treatment, symptom management, second opinions, and patient education. It also offers virtual visits and access to ongoing clinical trials.

Featured Care Team Members

Sam I. Hooshmand, DO
Neurology
Ahmed Zayed Obeidat, MD, PhD
Neurology
Michelle Maynard, PharmD, BCPS
Neurosciences Pharmacist

Specialized Programs

Multidisciplinary MS program
Neuropsychology support
Urology collaboration
Neuro-ophthalmology collaboration
Neurorehabilitation collaboration
Physical medicine and rehabilitation collaboration

Partnerships & Referral Network

  • Wisconsin Institute of NeuroScience (WINS)

Services & Treatments

What They Treat
Multiple sclerosisClinically isolated syndromeRelapsing-remitting multiple sclerosisSecondary-progressive multiple sclerosisPrimary-progressive multiple sclerosisProgressive-relapsing multiple sclerosisNeuromyelitis opticaImmune disorders of the central nervous system
How They Treat It
Team-based MS careMS symptom managementMS diagnosisMS treatmentPatient educationVirtual visitsSecond opinion consultationsSpecialty care coordinationSteroidsPlasma exchangeCyclophosphamideDisease-modifying medicationsRehabilitationPhysical therapyOccupational therapySpeech therapy
Diagnostics
MRIBrain MRILumbar punctureSpinal fluid analysisNeurological examinationState-of-the-art imaging

Research & Clinical Trials

This center is currently involved in 19 clinical trials — ranked #1 in Wisconsin for active trials

A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease
TScan Therapeutics, Inc.
RECRUITING
Companion blood samples with procedure
A Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation
Novartis Pharmaceuticals
ACTIVE NOT RECRUITINGPHASE4
OfatumumabDisease modifying treatment (DMT)
A Study of Obexelimab in Patients With Relapsing Multiple Sclerosis (MoonStone)
Zenas BioPharma (USA), LLC
ACTIVE NOT RECRUITINGPHASE2
ObexelimabPlacebo
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis
Hoffmann-La Roche
ACTIVE NOT RECRUITINGPHASE3
FenebrutinibOcrelizumabPlacebo matched to ocrelizumabPlacebo matched to fenebrutinib
A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
RECRUITINGPHASE1
CC-97540FludarabineCyclophosphamide
AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy
UniQure Biopharma B.V.
RECRUITINGPHASE1, PHASE2
AAV9-hSyn1-miGRIK2
An Open-label Study of AZD0120 in Adults With Multiple Sclerosis
AstraZeneca
RECRUITINGPHASE1
AZD0120 - Regimen 1AZD0120 - Regimen 2
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
National Institute of Allergy and Infectious Diseases (NIAID)
RECRUITINGPHASE3
Autologous Hematopoietic Stem Cell TransplantationBest Available Therapy (BAT)
Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)
Amgen
RECRUITINGPHASE3
Ocrelizumab (US)Ocrelizumab (EU)ABP 692
Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis
Sanofi
RECRUITINGPHASE3
FrexalimabTeriflunomidePlacebo infusionPlacebo tabletMRI contrast-enhancing agentsCholestyramineActivated charcoal
Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis
Sanofi
RECRUITINGPHASE3
FrexalimabPlaceboMRI contrast-enhancing agents
Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple Sclerosis
Novartis Pharmaceuticals
ACTIVE NOT RECRUITINGPHASE3
FingolimodOfatumumabSiponimodFingolimod placeboSiponimod placeboOfatumumab placebo
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
Novartis Pharmaceuticals
ACTIVE NOT RECRUITINGPHASE3
RemibrutinibTeriflunomide
High-Intensity, Dynamic-stability Gait Training in People With Multiple Sclerosis
Marquette University
RECRUITINGNA
High-Intensity Treadmill TrainingTreadmill Training with PerturbationsStandard Treadmill Training
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab
Novartis Pharmaceuticals
ACTIVE NOT RECRUITINGPHASE3
Ofatumumab approved doseOfatumumab new dose
Proof-of-concept Study for SAR441344 (Frexalimab) in Relapsing Multiple Sclerosis
Sanofi
ACTIVE NOT RECRUITINGPHASE2
SAR441344 IVplacebo IVSAR441344 SCplacebo SCMRI contrast-enhancing preparations
Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
Celgene
RECRUITINGPHASE3
OzanimodFingolimodPlacebo
Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)
Hoffmann-La Roche
ACTIVE NOT RECRUITINGPHASE3
FenebrutinibTeriflunomidePlacebo
Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial
Johns Hopkins University
ACTIVE NOT RECRUITINGNA
Natalizumab/natalizumab-sztn, Alemtuzumab, Ocrelizumab, Rituximab/rituximab-arrx/rituximab-abbs/rituximab-pvvr, Cladribine, Ofatumumab, Ublituximab-xiiy, Ocrelizumab and hyaluronidase-ocsqGlatiramer acetate, Interferons (intramuscular, subcutaneous, pegylated) Teriflunomide, Fumarates (dimethyl, diroximel, monomethyl) Fingolimod, Siponimod, Ozanimod, Ponesimod

Insurance & Access

Contact
Neurosciences Center, Froedtert Hospital, 9200 West Wisconsin Avenue, Milwaukee, WI 53226
Insurance & Support
Patient Portal

FAQs from Multiple Sclerosis Clinic at the Medical College of Wisconsin

The clinic treats multiple sclerosis, clinically isolated syndrome, and several MS subtypes, including relapsing-remitting, secondary-progressive, and primary-progressive MS. It also cares for neuromyelitis optica and other immune disorders of the central nervous system.

You can receive a neurological exam, MRI and brain MRI, lumbar puncture, and spinal fluid analysis as part of your evaluation. The clinic also uses imaging to help guide care.

Yes. Virtual visits are available, which can make follow-up and specialty care easier to access. For video visits, you must be physically in Wisconsin at the time of the appointment.

Yes, second opinion consultations are available. This can be helpful if you want another expert review of your diagnosis or treatment plan.

Your care can involve neurologists, neuropsychologists, nurses, physical and occupational therapists, speech therapists, urologists, ophthalmologists, neuro-ophthalmologists, neuroradiologists, and rehabilitation specialists. That broad team helps coordinate care around the many ways MS can affect daily life.

Compare Wisconsin MS Centers

CenterTypeInfusionVirtualExperience
Multiple Sclerosis Clinic at the Medical College of Wisconsin
Milwaukee
Academic MS Center3.4/5
Regional Neurology Group2.6/5
Dedicated MS Practice2.8/5
Community Hospital Program2.8/5
Academic MS Center2.4/5
Regional Neurology Group2.4/5

Check out the MS Buddy App

Track symptoms, monitor wellness, and stay on top of your MS care. It's free, no ads. How? It's made and supported by MS patients who get their ideas from other MS patients.

Download on the App StoreGet it on Google Play
Call Website Book